WEP CLINICAL ANNOUNCES NEW US OFFICE FACILITIES WEP Clinical (WEP) is excited to announce that it is moving its US office location, due to a period of rapid growth and development for the company. [...]

WEP Clinical and MendeliKABS Inc. enter exclusive Named Patient distribution agreement for MDK-Nitisinone WEP Clinical, a global pharmaceutical and services company, and MendeliKABS Inc., a Canadian pharmaceutical company dedicated to the treatment of rare diseases, [...]